Log in
NASDAQ:BPMC

Blueprint Medicines Earnings Date, Estimates & History

$88.00
-0.24 (-0.27 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$86.14
Now: $88.00
$88.82
50-Day Range
$66.45
MA: $74.99
$89.64
52-Week Range
$43.29
Now: $88.00
$91.82
Volume543,372 shs
Average Volume678,838 shs
Market Capitalization$4.86 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.04

Earnings

Blueprint Medicines (NASDAQ:BPMC) Earnings Information

Blueprint Medicines last posted its quarterly earnings results on July 30th, 2020. The biotechnology company reported ($2.28) earnings per share for the quarter, missing the consensus estimate of ($2.08) by $0.20. The firm had revenue of $8.34 million for the quarter, compared to the consensus estimate of $7.56 million. Blueprint Medicines has generated ($7.27) earnings per share over the last year. Blueprint Medicines has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 3rd, 2020 based off prior year's report dates.

Blueprint Medicines Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Blueprint Medicines (NASDAQ:BPMC) Earnings Estimates

2020 EPS Consensus Estimate: ($4.15)
2021 EPS Consensus Estimate: ($6.09)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203($2.13)($1.96)($2.05)
Q2 20205($2.13)($2.00)($2.07)
Q3 20205($1.85)$8.65$1.71
Q4 20205($2.38)($1.06)($1.74)
Q1 20212($1.76)($1.50)($1.63)
Q2 20213($1.74)($1.38)($1.55)
Q3 20213($1.55)($1.25)($1.44)
Q4 20212($1.82)($1.11)($1.47)

Blueprint Medicines (NASDAQ BPMC) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/3/2020
(Estimated)
       
7/30/20206/30/2020($2.08)($2.28)($2.28)$7.56 million$8.34 millionTranscript
5/6/20203/31/2020($2.08)($2.11)($2.11)$5.57 million$6.20 millionTranscript
2/13/2020Q4 2019($1.71)($1.35)($1.35)$26.00 million$51.53 millionTranscript
11/5/2019Q3 2019($2.19)($1.93)($1.93)$2.85 million$9.14 millionN/A
8/1/2019Q2 2019($1.92)($2.04)($2.04)$1.39 million$5.11 millionListen
5/9/20193/31/2019($1.83)($1.98)($1.98)$1.38 million$0.73 millionListen
2/26/2019Q4 2018($1.68)($1.83)($1.83)$1.77 million$1.03 millionListen
10/30/20189/30/2018($1.57)($1.66)($1.66)$1.87 million$1.10 millionListen
8/1/2018Q2 2018($1.32)($0.62)($0.62)$2.62 million$41.40 millionN/A
5/2/2018Q1 2018($1.06)($1.29)($1.29)$2.82 million$0.95 millionN/A
2/21/2018Q4 2017($1.07)($1.23)($1.23)$5.28 million$1.63 millionN/A
10/31/2017Q3 2017($0.90)($0.96)($0.96)$5.35 million$8.07 millionN/A
8/2/2017Q2 2017($0.75)($0.86)($0.86)$5.96 million$5.89 millionListen
5/3/2017Q1 2017($0.73)($0.84)($0.84)$6.02 million$5.84 millionListen
3/9/2017Q4 2016($0.76)($0.75)($0.75)$6.31 million$7.69 millionListen
11/10/2016Q316($0.77)($0.62)($0.62)$6.06 million$6.16 millionListen
8/9/2016Q216($0.73)($0.70)($0.70)$4.41 million$7.07 millionListen
5/10/2016Q116($0.70)($0.57)($0.57)$3.24 million$6.90 millionListen
3/11/2016Q415($0.53)($0.58)($0.58)$2.85 million$4.64 millionN/A
11/9/2015Q3($0.54)($0.47)($0.47)$1.83 million$3.43 millionN/A
8/10/2015Q2 2015($0.44)($0.81)($0.81)$0.94 million$2.69 millionN/A
6/11/2015Q1 2015($6.20)($8.23)($8.23)$0.94 million$0.65 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 9/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.